1 in 3 cardiac patients does not believe flu vacc needed

12 November 2007

A survey conducted by Harris Interactive on behalf of the US patient support group Mended Hearts has found that more than one in three heart disease patients (37%) does not plan to get an influenza vaccination this year. Despite a high risk of death resulting from flu among cardiac patients, barely half (53%) received the vaccine last year, according to the american Heart Association-affiliated group.

The US Department of Health and Human Services has set a target of 60% of heart disease patients aged less than 65 to receive flu vaccination, with 90% of all persons aged 65 or over. However, the AHA recommends that a nasal spray, instead of the live attenuated vaccine, should be employed in high-risk cases. Figures reported by the Centers for Disease Control and Prevention (CDC) suggest that 92,000 people may die each year of influenza-related cardiac events.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight